» Articles » PMID: 26113845

The Ins and Outs of RND Efflux Pumps in Escherichia Coli

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2015 Jun 27
PMID 26113845
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

Infectious diseases remain one of the principal causes of morbidity and mortality in the world. Relevant authorities including the WHO and CDC have expressed serious concern regarding the continued increase in the development of multidrug resistance among bacteria. They have also reaffirmed the urgent need for investment in the discovery and development of new antibiotics and therapeutic approaches to treat multidrug resistant (MDR) bacteria. The extensive use of antimicrobial compounds in diverse environments, including farming and healthcare, has been identified as one of the main causes for the emergence of MDR bacteria. Induced selective pressure has led bacteria to develop new strategies of defense against these chemicals. Bacteria can accomplish this by several mechanisms, including enzymatic inactivation of the target compound; decreased cell permeability; target protection and/or overproduction; altered target site/enzyme and increased efflux due to over-expression of efflux pumps. Efflux pumps can be specific for a single substrate or can confer resistance to multiple antimicrobials by facilitating the extrusion of a broad range of compounds including antibiotics, heavy metals, biocides and others, from the bacterial cell. To overcome antimicrobial resistance caused by active efflux, efforts are required to better understand the fundamentals of drug efflux mechanisms. There is also a need to elucidate how these mechanisms are regulated and how they respond upon exposure to antimicrobials. Understanding these will allow the development of combined therapies using efflux inhibitors together with antibiotics to act on Gram-negative bacteria, such as the emerging globally disseminated MDR pathogen Escherichia coli ST131 (O25:H4). This review will summarize the current knowledge on resistance-nodulation-cell division efflux mechanisms in E. coli, a bacteria responsible for community and hospital-acquired infections, as well as foodborne outbreaks worldwide.

Citing Articles

Bacterial Tolerance to 1-Butanol and 2-Butanol: Quantitative Assessment and Transcriptomic Response.

Arsov A, Petrova P, Gerginova M, Tsigoriyna L, Armenova N, Ignatova I Int J Mol Sci. 2025; 25(24.

PMID: 39769098 PMC: 11728337. DOI: 10.3390/ijms252413336.


Natural Solutions to Antimicrobial Resistance: The Role of Essential Oils in Poultry Meat Preservation with Focus on Gram-Negative Bacteria.

Kovacevic Z, cabarkapa I, Saric L, Pajic M, Tomanic D, Kokic B Foods. 2024; 13(23).

PMID: 39682977 PMC: 11640364. DOI: 10.3390/foods13233905.


Genomic insights on cgMLST markers, drug resistance, and urease cluster of strains.

Lian S, Liu Y, Hu S, Shen C, Ma Y, Yin P Microbiol Spectr. 2024; 13(1):e0099224.

PMID: 39641568 PMC: 11705806. DOI: 10.1128/spectrum.00992-24.


Physiological Effects of TolC-Dependent Multidrug Efflux Pumps in Escherichia coli: Impact on Motility and Growth Under Stress Conditions.

Di Maso A, Ruiz C Microbiologyopen. 2024; 13(6):e70006.

PMID: 39529380 PMC: 11554990. DOI: 10.1002/mbo3.70006.


Use of transcriptomics and genomics to assess the effect of disinfectant exposure on the survival and resistance of O157:H7, a human pathogen.

Kirchner M, Nunez-Garcia J, Duggett N, Gosling R, Anjum M Front Microbiol. 2024; 15:1477683.

PMID: 39507346 PMC: 11538004. DOI: 10.3389/fmicb.2024.1477683.


References
1.
Amaral L, Molnar J . Why and how thioridazine in combination with antibiotics to which the infective strain is resistant will cure totally drug-resistant tuberculosis. Expert Rev Anti Infect Ther. 2012; 10(8):869-73. DOI: 10.1586/eri.12.73. View

2.
Tikhonova E, Zgurskaya H . AcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex. J Biol Chem. 2004; 279(31):32116-24. DOI: 10.1074/jbc.M402230200. View

3.
Kvist M, Hancock V, Klemm P . Inactivation of efflux pumps abolishes bacterial biofilm formation. Appl Environ Microbiol. 2008; 74(23):7376-82. PMC: 2592912. DOI: 10.1128/AEM.01310-08. View

4.
Beloin C, Roux A, Ghigo J . Escherichia coli biofilms. Curr Top Microbiol Immunol. 2008; 322:249-89. PMC: 2864707. DOI: 10.1007/978-3-540-75418-3_12. View

5.
Kim E, Nies D, McEvoy M, Rensing C . Switch or funnel: how RND-type transport systems control periplasmic metal homeostasis. J Bacteriol. 2011; 193(10):2381-7. PMC: 3133179. DOI: 10.1128/JB.01323-10. View